Desai T, Gogate A, Deodhar L, Toddywalla S, Kelkar M
L.T.M. Medical College, Sion, Bombay.
Indian J Pathol Microbiol. 1993 Oct;36(4):348-55.
Two systems of Competitive Enzyme linked immunosorbent assay (ELISA) were developed to detect Mycobacterial antigen in cerebrospinal fluid (CSF) for the diagnosis of tuberculous meningitis (TBM)--one by using indigenously prepared Anti-M.tuberculosis H37Rv-Penicillinase conjugate (Method I) and another by using commercially available Anti M. bovis BCG-Horse Radish Peroxidase (HRP) conjugate--(Method II). The tests were used to analyse CSF of 148 patients clinically confirmed as having TBM and 278 control subjects. By using > or = 10 ng/ml as the cut-off value for Method I and > or = 1 ng/ml as that for Method II, the specificity for both were 100% and positivity was 79.73% and 67.57% respectively. A follow up study in 26 TBM cases after 2 weeks (16 cases), 4 weeks (13 cases) and 4-12 months (10 cases) of antituberculous treatment revealed that mycobacterial antigen persisted in the majority of cases even after 4 weeks of the treatment.
开发了两种竞争性酶联免疫吸附测定(ELISA)系统,用于检测脑脊液(CSF)中的结核分枝杆菌抗原,以诊断结核性脑膜炎(TBM)——一种使用国产抗结核分枝杆菌H37Rv - 青霉素酶偶联物(方法I),另一种使用市售的抗牛型结核分枝杆菌卡介苗 - 辣根过氧化物酶(HRP)偶联物——(方法II)。这些检测用于分析148例临床确诊为TBM的患者和278例对照受试者的脑脊液。以方法I的截断值≥10 ng/ml和方法II的截断值≥1 ng/ml计算,两者的特异性均为100%,阳性率分别为79.73%和67.57%。对26例TBM病例在抗结核治疗2周(16例)、4周(13例)和4 - 12个月(10例)后进行的随访研究显示,即使在治疗4周后,大多数病例中的结核分枝杆菌抗原仍持续存在。